跳至主要内容
临床试验/EUCTR2019-002118-37-ES
EUCTR2019-002118-37-ES进行中(未招募)1 期

MULTICENTER, DOUBLE BLIND CLINICAL TRIAL TO EVALUATE THE ANTIHEMORRAGIC EFFECT OF THE TOPICAL TRANEXAMIC ACID DURING PACEMAKER IN ANTICOAGULATED PATIENTS

Rafael Blancas-Gómez Casero0 个研究点目标入组 100 人开始时间: 2019年12月20日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • All patients undergoing implantation of definitive pacemakers, older than 18 years of age, who give their consent and receive anticoagulant therapy with acenocoumarol prior to the procedure
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 80

排除标准

  • Use of antiaggregant other than aspirin in the 5 days prior to implantation
  • INR> 3.5 or INR <2
  • Denial of informed consent

研究者

发起方
Rafael Blancas-Gómez Casero

相似试验